Posterior Wall Substrate Modification Using Irreversible Electroporation

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06085014` - Clinical and Electrophysiological Predictors of Arrhythmic Recurrence in Patients With Paroxysmal AF Undergoing First Ablation Procedure of AF by Pulmonary Vein Isolation
Recruiting	`NCT03724383` - Atrial Fibrillation Lifestyle Project	N/A
Active, not recruiting	`NCT04544397` - Outcomes of Second Generation Laser Balloon Ablation for Atrial Fibrillation
Not yet recruiting	`NCT05940597` - Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation	N/A
Not yet recruiting	`NCT04447300` - Outcomes of High Power Application in Catheter Ablation of Paroxysmal Atrial Fibrillation Guided by Unipolar Signal Modification.	N/A
Recruiting	`NCT05251545` - Randomized Trial: High Power Short Duration Versus Ablation Index	N/A
Recruiting	`NCT05883631` - RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.	N/A
Not yet recruiting	`NCT04600713` - Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.	N/A
Enrolling by invitation	`NCT05725187` - Prospective Validation Study of AI-based Prediction Algorithm for the Prediction of Paroxysmal Atrial Fibrillation
Recruiting	`NCT04606693` - Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates	N/A
Recruiting	`NCT05328882` - Early Recurrences of Atrial Arrhythmias and Their Impact on Late Recurrence After Pulmonary Vein Isolation With Pulsed Field Ablation of Paroxysmal Atrial Fibrillation
Recruiting	`NCT04342312` - Intensive Molecular and Electropathological Characterization of Patients Undergoing Atrial Fibrillation Ablation
Recruiting	`NCT05549752` - Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia	Phase 3
Completed	`NCT03323099` - Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation	N/A
Completed	`NCT05461859` - Cardioneuroablation for the Treatment of Vagally-mediated Atrial Fibrillation.
Enrolling by invitation	`NCT04634461` - The Relationship Between Panic Attack Symptoms and Atrial Fibrillation Episodes.
Completed	`NCT04023461` - Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients	Phase 4
Recruiting	`NCT06392932` - Esophageal Temperature During PVI Using Q-DOT Micro	N/A
Recruiting	`NCT05292209` - RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring	Phase 2
Completed	`NCT04511520` - Efficacy of Personalized Exercise Program and Trimetazidine in Rehabilitation of Patients After RFA of AF	N/A

NCT number	NCT06364215
Study type	Interventional
Source	Brigham and Women's Hospital
Contact	Obadah Aloum, MD
Phone	6177325241
Email	oaloum@bwh.harvard.edu
Status	Not yet recruiting
Phase	N/A
Start date	June 2024
Completion date	December 2025

Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation — (SMILE-AF)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms